Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore professional investment ideas sourced from institutional letters, short theses, and premium research channels, distilled into concise summaries.
| Pitch Type | Author | Industry | Pitch Thesis & Key Summary | Bull/Bear | Action | ||
|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | Fund Letter | Christopher SmithArtisan Focus Fund | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Short MDT (Medtronic plc) Medtronic is cited as an example of a potential value trap that appears optically cheap at 15X EPS but fails to generate an ROIC above its cost of capital. Over time, its... | BEAR | View Pitch → | |
| Jul 31, 2026 | Other | Polen Capital - International Growth | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Polen Capital – International Growth – MDT We also sold our position in Medtronic. We continue to... | NEUTRAL | View Pitch → | |
| Jan 9, 2026 | Fund Letter | Dr Ian Mortimer, CFAGuinness Global Innovators | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Guinness Global Innovators 2025 Q4 (MDT) Medtronic (+16.3%, USD) was the portfolio's best-performing company during the month. The leading medical... | BULL | View Pitch → |
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.
Zero Spam • High Alpha • Unsubscribe Anytime
Investment pitches and theses displayed on Buyside Digest are summaries of opinions expressed in publicly available investor letters, research reports, or other commentary. These summaries are generated for informational and research purposes only and do not constitute investment recommendations, financial advice, or an endorsement of any particular security or strategy by Buyside Digest. Users should conduct their own independent due diligence and consult with professional advisors before making any investment decisions.